BioStem Technologies, Inc. (BSEM)
NASDAQ: BSEM · Real-Time Price · USD
3.680
+0.335 (10.01%)
At close: Aug 20, 2026, 4:00 PM EDT
3.770
+0.090 (2.44%)
After-hours: Aug 20, 2026, 4:50 PM EDT
BioStem Technologies Market Cap
BioStem Technologies has a market cap or net worth of $65.69 million as of August 20, 2026.
Market Cap
65.69M
Enterprise Value
59.95M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.68
ChartMarket Cap Chart
Since August 7, 2026, BioStem Technologies's market cap has decreased from $69.50M to $65.69M, a decrease of -5.49%. That is a compound annual growth rate of -79.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 65.69M | 10.03% |
| Aug 19, 2026 | 59.70M | 6.23% |
| Aug 18, 2026 | 56.20M | 5.05% |
| Aug 17, 2026 | 53.50M | -6.63% |
| Aug 14, 2026 | 57.30M | 3.62% |
| Aug 13, 2026 | 55.30M | -18.44% |
| Aug 12, 2026 | 67.80M | 10.60% |
| Aug 11, 2026 | 61.30M | -4.52% |
| Aug 10, 2026 | 64.20M | -7.63% |
| Aug 7, 2026 | 69.50M | - |
View and export this data all the way back to 2026. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MiNK Therapeutics | 55.90M |
| eXoZymes | 54.94M |
| Immutep | 54.49M |
| Edesa Biotech | 54.43M |
| RenovoRx | 54.16M |
| Alps Group | 53.28M |
| TScan Therapeutics | 53.11M |
| Apollomics | 51.72M |